Carcinoma, Merkel Cell - 24 Studies Found
| Completed |
: QUILT-3.009: Study of aNK Infusions in Combination With ALT-803 in Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC) :
|
| Completed |
: S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer : Neuroendocrine Carcinoma of the Skin : 1999-11-01 :
|
| Active, not recruiting |
: Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma :
: 2013-12-19 : Drug: Cabozantinib Cabozantinib 60 mg Oral Daily 28 days (4 weeks) |
| Completed |
: A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma : Metastatic Melanoma and Merkel Cell Carcinoma : 2012-07-12 :
|
| Active, not recruiting |
: Merkel Positron Emission Tomography (PET) Protocol : Merkel Cell Carcinoma : 2009-11-12 :
|
| Completed |
: Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma :
: 2017-03-01 :
|
| Active, not recruiting |
: Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer :
|
| Recruiting |
: Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma :
|
| Completed |
: S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer :
|
| Completed |
: A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors :
|